JMML genomics and decisions
CM Niemeyer - Hematology 2014, the American Society of …, 2018 - ashpublications.org
Juvenile myelomonocytic leukemia (JMML) is a unique clonal hematopoietic disorder of
early childhood characterized by hyperactivation of the RAS signal transduction pathway …
early childhood characterized by hyperactivation of the RAS signal transduction pathway …
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia
F Locatelli, M Algeri, P Merli… - Expert review of …, 2018 - Taylor & Francis
Introduction: Juvenile myelomonocytic leukemia (JMML) is a clonal hematopoietic disorder
of infancy/early childhood, resulting from oncogenic mutations in genes involved in the Ras …
of infancy/early childhood, resulting from oncogenic mutations in genes involved in the Ras …
[HTML][HTML] Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
AL Gagne, JA Maguire, S Gandre-Babbe, ST Chou… - Stem cell …, 2018 - Elsevier
Juvenile myelomonocytic leukemia (JMML) is a rare myeloproliferative disorder of early
childhood characterized by expansion of clonal myelomonocytic cells and hyperactive …
childhood characterized by expansion of clonal myelomonocytic cells and hyperactive …
[PDF][PDF] Juvenile myelomonocytic leukemia in turkey: a retrospective analysis of sixty-five patients
Objective: This study aimed to define the status of juvenile myelomonocytic leukemia
(JMML) patients in Turkey in terms of time of diagnosis, clinical characteristics, mutational …
(JMML) patients in Turkey in terms of time of diagnosis, clinical characteristics, mutational …
[HTML][HTML] Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
Abnormalities of molecules involved in signal transduction pathways are connected to
Chronic Lymphocytic Leukemia (CLL) pathogenesis and a critical role has been already …
Chronic Lymphocytic Leukemia (CLL) pathogenesis and a critical role has been already …
Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know
RP Hasserjian - Current opinion in hematology, 2018 - journals.lww.com
The growing body of genetic data have not only altered the classification of myeloid
neoplasms, but are also impacting patient management. Genetically-defined disease …
neoplasms, but are also impacting patient management. Genetically-defined disease …
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma
M Alon, R Emmanuel, N Qutob… - Pigment cell & …, 2018 - Wiley Online Library
The NRAS oncoprotein is highly mutated in melanoma. However, to date, no comprehensive
proteomic study has been reported for NRAS. Here, we utilized the endogenous epitope …
proteomic study has been reported for NRAS. Here, we utilized the endogenous epitope …
Pathology of the Chronic Myeloid Leukemias
BJ Bain - Neoplastic Diseases of the Blood, 2018 - Springer
The chronic myeloid leukemias are a heterogeneous group of hematological neoplasms
resulting from mutation in either a myeloid progenitor or stem cell, leading to a purely …
resulting from mutation in either a myeloid progenitor or stem cell, leading to a purely …
[PDF][PDF] PIGMENT CELL & MELANOMA Research
M Alon, R Emmanuel, N Qutob, A Bakhman, V Peshti… - koslofflab.haifa.ac.il
The NRAS oncoprotein is highly mutated in melanoma. However, to date, no comprehensive
proteomic study has been reported for NRAS. Here, we utilized the endogenous epitope …
proteomic study has been reported for NRAS. Here, we utilized the endogenous epitope …
Novel Genetic Causes of Cerebral and Systemic Vasculopathies
AAL Keylock - 2018 - discovery.ucl.ac.uk
Vasculopathies are a varied group of disorders that affect the vascular tree resulting in
arterial stenosis or dilatation causing multi-organ ischaemia and significant cardiac and …
arterial stenosis or dilatation causing multi-organ ischaemia and significant cardiac and …